|
|
||||||||

,


*
Division of Immunobiology, University of Bonn, Bonn, Germany;
Human Immunogenetics Laboratory, Imperial Cancer Research Fund, London, United Kingdom; and
Department of Cellular Biochemistry, The Netherlands Cancer Institute, Amsterdam, The Netherlands
The detection of dimers of dimers in MHC class II crystals has
excited speculation about their possible functions in T cell Ag
recognition. Biochemical evidence for the existence of DR superdimers
falls short of proof and is controversial. To monitor B lymphoma cells
for high m.w. complexes of HLA-DR molecules, membrane preparations and
cell lysates were screened by one- and two-dimensional Western
blotting. Under these conditions, in which DR
ß heterodimers were
readily detected, no DR complexes with an (
ß)2-chain
composition could be identified. Two mAbs (L243 and D1-12)
immunoprecipitated high m.w. DR complexes suspected to be superdimers.
However, biochemical analysis revealed that, rather than superdimers,
these were SDS-stable complexes of DR in combination with the Abs.
Thus, previous observations of HLA-DR superdimer bands may also reflect
complexes of DR molecules with bound Ab.
This article has been cited by other articles:
![]() |
H. Li, Y. Zhao, Y. Guo, Z. Li, L. Eisele, and W. Mourad Zinc Induces Dimerization of the Class II Major Histocompatibility Complex Molecule That Leads to Cooperative Binding to a Superantigen J. Biol. Chem., March 2, 2007; 282(9): 5991 - 6000. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Muntasell, M. Carrascal, I. Alvarez, L. Serradell, P. van Veelen, F. A. W. Verreck, F. Koning, J. Abian, and D. Jaraquemada Dissection of the HLA-DR4 Peptide Repertoire in Endocrine Epithelial Cells: Strong Influence of Invariant Chain and HLA-DM Expression on the Nature of Ligands J. Immunol., July 15, 2004; 173(2): 1085 - 1093. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lindstedt, N. Monk, G. Lombardi, and R. Lechler Amino Acid Substitutions in the Putative MHC Class II ""Dimer of Dimers"" Interface Inhibit CD4+ T Cell Activation J. Immunol., January 15, 2001; 166(2): 800 - 808. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |